Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-04-06

FDA Approved: DAPAGLIFLOZIN — Original Application (Sandoz Inc)

View source ↗

Summary

FDA approves Sandoz's generic dapagliflozin under Original Application. The approval makes a generic version available for the same indications as the reference…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin (dapagliflozin)

Snippet

ORIG AP for DAPAGLIFLOZIN (DAPAGLIFLOZIN)